Currently Viewing:
Currently Reading
Can Rituximab Delay Disease Progression in SPMS?
January 19, 2019 – Samantha DiGrande
Tumor Mutational Burden Predicts Who Will Respond to Immunotherapy
January 19, 2019 – Jaime Rosenberg
Once-Weekly Carfilzomib Improves PFS, OS in High-Risk Patients With MM Over Twice-Weekly Dose
January 19, 2019 – Laura Joszt
PCT Just as Effective as MASCC for Predicting Serious Complications in Febrile Neutropenia
January 18, 2019 – Jaime Rosenberg
Researchers Document Links Between Pollution Levels, ED Visits for Breathing Problems
January 18, 2019 – Allison Inserro
CMS Expands VBID in Medicare Advantage, Increases Risk Sharing in Part D
January 18, 2019 – Allison Inserro
Tracking Medicaid Expansion
January 18, 2019 – AJMC Staff
This Week in Managed Care: January 18, 2019
January 18, 2019
USPSTF Releases Draft Recommendation on Drugs to Lower Risk of Breast Cancer
January 18, 2019 – Samantha DiGrande

DOJ Clears Cigna–Express Scripts Merger

AJMC Staff
The approval comes 6 months after the 2 companies fist made an announcement of the proposed merger.
It's official: Cigna can acquire the largest pharmacy benefits manager (PBM) in the United States, Express Scripts, for a whopping $67 billion after receiving clearance from the Antitrust Division of the United States Department of Justice (DOJ).

“We are pleased that the Department of Justice has cleared our transaction and that we are another step closer to completing our merger and delivering greater affordability, choice and predictability to our customers and clients as a combined company,” said David Cordani, president and CEO of Cigna, in a statement.

The announcement of the merger was first made back in March 2018, with plans for $48.75 billion in cash exchange and the remaining amount as stock. A majority (90%) of Cigna’s shareholders approved of the deal in an August vote.

“Together, we believe we will be able to do even more to reduce healthcare costs, expand choice, and improve patient outcomes,” said Tim Wentworth, president and CEO of Express Scripts, reacting to the approval. “Today’s decision is one more important milestone in our effort to combine two innovative health services leaders into a company that will transform health care.”

Till date, the 2 companies have worked with insurance regulators in 16 states and plan to continue working with officials in other states to gain clearance for the merger.

Cordani will head the combined company and Wentworth will remain president of the PBM.

The deal is expected to close toward the end of 2018.

Related Articles

PBMs Can Help Bend the Cost Curve: Express Scripts' Tim Wentworth
Express Scripts to Give Refunds if Patients Don't Stay on Expensive Drugs
Aetna, Humana Call Off $37 Billion Merger; Cigna Sues Anthem for $13 Billion
Healthcare Mergers Continue With Deal for Cigna to Acquire Express Scripts
What We're Reading: Protections for Pre-existing Conditions; Shareholders Approve Cigna–Express Scripts Deal; Aspirin and CV Risk
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!